http://www.fpnotebook.com/
Prevention of Kidney Disease ProgressionAka: Chronic Kidney Disease Prevention
- See Also
- Chronic Kidney Disease
- Intravenous Contrast Related Acute Renal Failure
- Drug Dosing in Chronic Kidney Disease
- Management: Nephrology consultation indications
- Glomerular Filtration Rate <30 ml/min or
- Assistance with evaluation or management strategy
- Management: Fluids, electrolytes and nutrition
- Careful fluid balance (avoid Fluid Overload as well as dehydration)
- Protein restriction (controversial)
- Low Protein diet
- Serum Creatinine 2-4 (GFR 25-55): 0.8 mg/kg/day
- Serum Creatinine >4 (GFR <25): 0.6 mg/kg/day
- Institute when Serum Creatinine >= 1.7
- Appears to significantly benefit only Diabetics
- Contraindications to protein restriction
- Hemodialysis
- Elderly
- Malnutrition
- Nephrotic Syndrome (due to high protein losses)
- Hyperkalemia
- Limit Dietary Potassium intake to 70 meq/day
- Metabolic Acidosis
- Unintentional Weight Loss
- Minimum intake: 35 Kcal/kg/day
- Hyperphosphatemia (renal osteodystrophy)
- Causes Osteitis fibrosa cystica (poor bone strength)
- Results from Hyperparathyroidism
- Management
- Restrict dietary phosphate (limit to 1200 mg/day)
- Avoid soda
- Avoid nuts, peas or beans
- Avoid dairy products
- Medications
- Calcium Supplementation 1-2 grams daily
- Phosphate-binding: Calcium Carbonate
- Vitamin D Supplementation (critical!)
- Management: Comorbid conditions
- Maximize glycemic control in Diabetes Mellitus
- Observe closely for Coronary Artery Disease
- High Incidence of comorbidity
- Most ESRD patients die of CAD before dialysis
- Control Hyperlipidemia (Statin drugs are preferred)
- Goal LDL Cholesterol <100 mg/dl
- Goal Triglycerides <200 mg/dl
- Avoid additional kidney injury
- Early recognition and treatment of UTI
- Avoid volume depletion
- Avoid Nephrotoxic Drugs
- Tobacco Cessation
- Limit radiologic Contrast Material to low density
- Management: Evaluate and manage common complications
- Anemia (Hemoglobin <11 grams per dl)
- Iron supplement indicated for Ferritin <100 ng/ml
- Erythropoetin or Aranesp indications
- Anemia dependent Angina
- Hemoglobin <10 grams/dl or Hematocrit <30-32
- Management: Hypertension and Proteinuria
- Most important preventive measure
- Control Hypertension and Proteinuria with ACE Inhibitor
- ACE Inhibitor should be first antihypertensive used
- Efficacious in Diabetic Nephropathy
- Efficacious in non-diabetic renal disease
- Jafar (2001) Ann Intern Med 135:73
- Indication
- Proteinuria on Urinalysis (1+ Protein on Urinalysis or >1 gram per day)
- Microalbuminuria in Diabetes Mellitus
- Hypertension (Blood Pressure >130/80 mmHg)
- Observe for Hyperkalemia
- Avoid with potassium sparing Diuretic
- Avoid with Potassium Supplementation
- Management with adverse effects
- Orthostasis: Maximize clear fluid intake
- Adjunctive antihypertensive agents
- Step 1: ACE Inhibitor or Angiotensin Receptor Blocker
- See above
- Step 2: Non-Dihydropyridine Calcium Channel Blocker
- Diltiazem or
- Verapamil
- Step 3: Hydrochlorothiazide
- Not helpful if Creatinine Clearance <30 ml/min
- Step 4: Beta Blocker
- Use with caution due to possible adverse outcomes
- References
- (2002) Am J Kidney Dis 39:S1
- Snively (2004) Am Fam Physician 70:1921
- Stigant (2003) CMAJ 168:1553
Navigation Tree